This multicenter, epidemiological observational study represents the most extensive investigation of the frequency, anatomical distribution, and mutation spectrum of KRAS mutations in metastatic colorectal cancer (mCRC) patients across Turkey. This evidence concerns the gene KRAS and metastatic colorectal cancer.